Cargando…

Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus

The COVID-19 pandemic is still affecting many people worldwide and causing a heavy burden to global health. To eliminate the disease, SARS-CoV-2, the virus responsible for the pandemic, can be targeted in several ways. One of them is to inhibit the 2′-O-methyltransferase (nsp16) enzyme that is cruci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulimov, Alexey, Kutov, Danil, Ilin, Ivan, Xiao, Yibei, Jiang, Sheng, Sulimov, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100384/ https://www.ncbi.nlm.nih.gov/pubmed/35566072 http://dx.doi.org/10.3390/molecules27092721

Ejemplares similares

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
por: Sulimov, Alexey, et al.
Publicado: (2022)

Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations
por: Sulimov, Alexey, et al.
Publicado: (2022)

Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021)

Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
por: Novichikhina, Nadezhda, et al.
Publicado: (2020)

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
por: Tashchilova, Anna, et al.
Publicado: (2022)

Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
por: Sulimov, A. V., et al.
Publicado: (2022)

Evaluation of Docking Target Functions by the Comprehensive Investigation of Protein-Ligand Energy Minima
por: Oferkin, Igor V., et al.
Publicado: (2015)

Evaluation of the novel algorithm of flexible ligand docking with moveable target-protein atoms
por: Sulimov, Alexey V., et al.
Publicado: (2017)

Application of Molecular Modeling to Development of New Factor Xa Inhibitors
por: Sulimov, Vladimir B., et al.
Publicado: (2015)

Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor
por: Wu, Qianqian, et al.
Publicado: (2022)

High-resolution structures of the SARS-CoV-2 2’-O-methyltransferase reveal strategies for structure-based inhibitor design
por: Rosas-Lemus, Monica, et al.
Publicado: (2020)

Peptide inhibitors against SARS-CoV-2 2′-O-methyltransferase involved in RNA capping: A computational approach
por: Dutta, Mainak, et al.
Publicado: (2021)

Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2
por: Sharma, Kedar, et al.
Publicado: (2020)

Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
por: Štefek, Milan, et al.
Publicado: (2023)

Combined Docking with Classical Force Field and Quantum Chemical Semiempirical Method PM7
por: Sulimov, A. V., et al.
Publicado: (2017)

RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION
por: Rowaiye, Adekunle B., et al.
Publicado: (2022)

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation
por: Novichikhina, Nadezhda P., et al.
Publicado: (2023)

Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 M(pro))
por: Zhang, Kuojun, et al.
Publicado: (2023)

3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
por: Bobileva, Olga, et al.
Publicado: (2023)

Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
por: Silhan, Jan, et al.
Publicado: (2023)

Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases
por: Bergant, Valter, et al.
Publicado: (2022)

Coronavirus 2′-O-methyltransferase: A promising therapeutic target
por: Schindewolf, Craig, et al.
Publicado: (2023)

Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
por: Guo, Liyan, et al.
Publicado: (2023)

In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations
por: El Hassab, Mahmoud A., et al.
Publicado: (2021)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies
por: Mehyar, Nimer
Publicado: (2023)

Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro
por: Miropolskaya, Nataliya, et al.
Publicado: (2023)

Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate
por: Bobiļeva, Olga, et al.
Publicado: (2021)

Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021)

Biology of the SARS-CoV-2 Coronavirus
por: Mingaleeva, Rimma N., et al.
Publicado: (2023)

Molecular Virology of SARS-CoV-2 and Related Coronaviruses
por: Kung, Yu-An, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
por: Benoni, Roberto, et al.
Publicado: (2021)

In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex
por: Liang, Julia, et al.
Publicado: (2021)

Virtual screening of molecular databases for potential inhibitors of the NSP16/NSP10 methyltransferase from SARS-CoV-2
por: Gomes, João Pedro Agra, et al.
Publicado: (2022)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase
por: Basu, Souradeep, et al.
Publicado: (2021)

Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2
por: Balieiro, Alessandra M., et al.
Publicado: (2022)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
por: Al-Khalaifah, Hanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rmou7ej11b56crd8cfvktot13b